Acute Myelocytic Leukemia

Search Trials
A Study to Evaluate the Efficacy and Safety of Maralixibat in Subjects With Progressive Familial Intrahepatic Cholestasis (MARCH-PFIC)
Status:
Recruiting
Last Changed:
Aug 7, 2019
First Changed:
Apr 5, 2019
Disease(s):
Progressive Familial Intrahepatic Cholestasis (PFIC)
Intervention(s):
MaralixibatPlacebo
A Placebo-controlled Study of Maralixibat (SHP625) in Pediatric Subjects With Progressive Familial Intrahepatic Cholestasis (PFIC)
Status:
Withdrawn
Last Changed:
Mar 18, 2019
First Changed:
Nov 27, 2017
Disease(s):
Progressive Familial Intrahepatic Cholestasis (PFIC)
Intervention(s):
MaralixibatPlacebo
Study Evaluating Safety and Efficacy of CAR-T Cells Targeting CD123 in Patients With Acute Myelocytic Leukemia
Status:
Recruiting
Last Changed:
Jan 11, 2019
First Changed:
Jan 8, 2019
Disease(s):
Acute Myelocytic Leukemia
Intervention(s):
CD123 CAR-T cells
Lintuzumab-Ac225 in Combination With CLAG-M Chemotherapy in Patients With Relapsed/Refractory Acute Myeloid Leukemia
Status:
Recruiting
Last Changed:
May 24, 2018
First Changed:
Feb 21, 2018
Disease(s):
Acute Myeloid Leukemia
Intervention(s):
Lintuzumab AC 225CladribineCytarabineMitoxantroneG-csf
Trial of Daily Pulse Interleukin-2 With Famotidine in Acute Myelogenous Leukemia
Status:
Terminated
Last Changed:
Mar 8, 2017
First Changed:
Feb 4, 2011
Disease(s):
Acute Myelogenous Leukemia
Intervention(s):
Interleukin-2

Connect. Empower. Inspire.